Library›Substances and pharmacology›Bacteriophages Endolysins and Biological Inhibitors

Bacteriophages Endolysins and Biological Inhibitors

Bacteriophages, Endolysins, and Biological Inhibitors examines the molecular biology of bacterial viruses, phage-encoded peptidoglycan-degrading enzymes (endolysins or "enzybiotics"), and the evolutionary arms race of biological inhibitors—most notably phage-encoded Anti-CRISPR (Acr) proteins and bacterial restriction-modification systems.

While classical pharmacology focuses on small-molecule synthetic drugs that inhibit human metabolic enzymes, biological systems have evolved macromolecular protein inhibitors and predatory nanomachines that regulate bacterial populations with atomic precision.

Bacteriophages: the biological predators of bacteria

Bacteriophages (phages) are viruses that exclusively infect bacteria. With an estimated global population exceeding $10^{31}$ individual virions, phages are the most abundant biological entities on Earth, turning over roughly 20% to 40% of the planetary bacterial biomass each day:

<code>

[ Bacteriophage Virion ] ──► ( Adsorption to Bacterial Surface Receptor )

│

▼ Genome Injection (DNA / RNA)

┌────────────────────────────────┴────────────────────────────────┐

▼ ▼

[ Lytic Pathway ] [ Lysogenic Pathway ]

• Immediate viral replication • Phage DNA integrates into host

• Holin-endolysin synthesis chromosome as a prophage

• Explosive host cell lysis • Replicates silently with host

• Progeny virions released • Induction triggered by UV / stress

</code>

Lytic cycle: The phage hijacks host transcriptional and translational machinery to synthesize viral structural proteins and replicate its genome, culminating in programmed host lysis.
Lysogenic cycle: Temperate phages integrate their genome into the bacterial chromosome as a dormant "prophage," replicating silently alongside the host until environmental stress (e.g., DNA damage, UV radiation) induces excision and activation of the lytic cascade.

The lytic enzyme machine: Holins and Endolysins

To release newly assembled viral progeny, double-stranded DNA phages deploy a tightly timed, two-component enzymatic lysis system:

<code>

[ Inner Bacterial Membrane ] ──► Holins form micron-scale pores at genetically programmed time

│

▼

[ Periplasmic Space ] ──► Endolysins pass through pores into peptidoglycan layer

│

▼

[ Peptidoglycan Cleavage ] ──► Rapid enzymatic hydrolysis of cell wall backbone

│

▼

[ Osmotic Lysis ] ──► High turgor pressure causes explosive bacterial rupture

</code>

1. Holin timing proteins

Holins are small hydrophobic inner membrane proteins that accumulate harmlessly in the cytoplasmic membrane during viral assembly.
At a genetically pre-programmed threshold concentration, holins suddenly undergo cooperative oligomerization, forming large, non-specific "holes" or pores in the lipid bilayer.
This depolarizes the membrane and allows periplasmic access to the true catalytic engine: the endolysin.

2. Endolysins: the "Enzybiotics"

Endolysins are phage-encoded peptidoglycan hydrolases. Once released past the inner membrane, they target and rapidly hydrolyze the structural bonds of the bacterial cell wall:

Catalytic classes:

** Glycosidases (Lysozymes / Muramidases): Cleave the $\beta(1\rightarrow4)$ glycosidic bonds between N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG).

** Endopeptidases: Hydrolyze peptide bonds within the cross-linking peptide stems.

** Amidases: Cleave the amide bond connecting the glycan strand to the peptide cross-link.

The Enzybiotic Revolution:

** When applied exogenously to Gram-positive bacteria, purified recombinant endolysins destroy the peptidoglycan wall from the outside in seconds, causing rapid osmotic lysis.

** Unlike broad-spectrum small-molecule antibiotics, endolysins possess narrow species specificity, killing target pathogens (such as *Staphylococcus aureus* / MRSA, *Streptococcus pneumoniae*, or *Clostridioides difficile*) without harming commensal human microbiome communities.

** Because endolysins target highly conserved structural bonds essential for bacterial survival, bacteria rarely develop clinical resistance.

Biological inhibitor systems: the CRISPR-Phage arms race

Bacteria and bacteriophages have engaged in billions of years of molecular co-evolution, generating complex macromolecular defense mechanisms and counter-inhibitors:

<code>

[ Bacterial Defense: CRISPR-Cas ] ──► ( Recognizes & cleaves foreign phage DNA )

│

▼

[ Phage Counter-Attack: Anti-CRISPR ] ──► ( Acr proteins bind and inactivate Cas enzymes )

│

▼

[ Outcome ] ──► Phage evades immune destruction and replicates

</code>

1. Bacterial defense systems

Restriction-Modification (R-M) Systems: Bacteria produce sequence-specific restriction endonucleases that cleave unmethylated foreign DNA, while self-DNA is protected by host methyltransferases.
CRISPR-Cas Systems: Adaptive immune RNA-guided endonucleases (such as Cas9, Cas12, Cas13) that utilize stored crRNA guides to recognize and cleave matching invading phage DNA or RNA sequences.

2. Anti-CRISPR (Acr) inhibitor proteins

To overcome bacterial immunity, phages encode small, highly potent biological inhibitor proteins known as Anti-CRISPRs (Acrs):

AcrIIA4: A direct protein mimic of the target DNA PAM site that binds tightly into the catalytic pocket of Streptococcus pyogenes Cas9 (SpCas9), sterically blocking guide-target DNA hybridization and preventing DNA cleavage.
AcrIF1 / AcrIF2: Inhibit Type I CRISPR-Cas systems by sterically blocking the Cas subtype complex or preventing target DNA recruitment.
Synthetic Biology Application: In human medicine and genetic engineering, Acr proteins function as "off-switches" for CRISPR gene editing, preventing off-target genomic cuts by disabling Cas9 after desired therapeutic edits are completed.

Phage-Antibiotic Synergy (PAS) and evolutionary trade-offs

Phage-Antibiotic Synergy (PAS): Co-administering sub-lethal concentrations of classical antibiotics (such as $\beta$-lactams or fluoroquinolones) with phages induces bacterial filamentation and cell swelling, dramatically accelerating phage burst size and speeding clearing of recalcitrant biofilms.
Evolutionary steering (The Phage Trap): Many phages use bacterial antibiotic efflux pumps (e.g., the MexAB-OprM multidrug efflux pump in *Pseudomonas aeruginosa*) or lipopolysaccharide (LPS) capsules as their attachment receptors. When bacteria mutate to resist phage infection, they frequently lose or downregulate these efflux pumps, resensitizing multi-drug resistant bacteria to conventional antibiotics.

Filed under Substances and pharmacology Organic chemistry and synthesis